Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane for Sedation in Acute Respiratory Distress Syndrome
NCT04235608Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- May 2020
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sevoflurane in acute respiratory distress syndrome (ARDS), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started May 2020; status: completed.
02
Drugs
sevoflurane
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04235608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04235608.